Vaniam Group’s Post

Have you seen the latest feature in Health Tech World? Dr. Emiliano Calvo Aller and Dr. Victor Moreno, Directors of Clinical Research at START Madrid-CIOCC and START Madrid-FJD, respectively, share their insights on Spain's evolving landscape of early-phase oncology trials. In this article, they take you through how Spain became a leader in oncology trials, the need for patient access to clinical trials within the community setting, and the exciting developments in personalized medicine and cell therapy. As Dr. Calvo said so beautifully, "For many cancer patients, participating in a Phase I clinical trial may be their only feasible option for accessing a potentially successful treatment. In these cases, access to a trial can be a much-needed source of hope." Read the full article here: https://lnkd.in/eqfUd3gs #OncologyResearch #ClinicalTrials #HealthTechWorld

📰 Looking for the latest insights on what experts are calling the "revolution in lung cancer"? 🌟 Don't miss our coverage of The Oncology Brothers Advancements in Oncology event, which provided key updates on lung cancer during #ASCO24! The event, moderated by Rahul Gosain, MD, MBA, and Rohit Gosain, MD, featured expert perspectives on lung cancer from panelist Rami Manochakian, MD, FASCO. ➡ Check out our exclusive coverage of the event here: https://lnkd.in/gZRAvJXn #lcsm #ASCO24

An honor to have been a part of this significant manuscript, just out in Annals of Oncology Annals of Oncology driving forward the clinical development of ADCs - Antonio Passaro IEO European Institute of Oncology https://lnkd.in/gwniKmWN #oncodaily #oncology #cancer #ADCs #AnnalsofOncology #clinicaldevelopment #lungcancer #breastcancer #research #positionstatement #ETOP #IBCSG #clinicaloutcomes #medicalresearch

Thoroughly looking forward to this American Society of Clinical Oncology (ASCO)24 joint session with AACR Journals, 'Drugging the ‘Undruggable’ Target - Lynn Schuchter Patricia LoRusso #AACR #Collaboration #ASCO24 #Cancer #CancerResearch #CancerTreatment #OncoDaily #Oncology

🚨 New Paper Alert! 🚨 A Comprehensive Review of ADCs in Lung and Breast Cancer by the ETOP IBCSG Partners Foundation Annals of Oncology Annals of Oncology ESMO - European Society for Medical Oncology Authors: Peters Solange, Sherene Loi, fabrice andre, Sarat Chandarlapaty, Enriqueta Felip, Stephen Finn, Pasi Jänne, Keith Kerr, Elisabetta Munzone, Antonio Passaro, Maurice Pérol, Egbert Smit, Charles Swanton, Giuseppe Viale, Rolf Stahel Summary by: Amalya Sargsyan https://lnkd.in/gt_P92f2 #oncodaily #oncology #cancer #AntibodyDrugConjugates #ADCs #ThoracicMalignancies #BreastCancer #TherapeuticModality #TreatmentStrategies #ClinicalReview #AnnalsOfOncology

A transformative “Vision for democratizing Next-Generation Oncology Clinical Trials” - Vivek Subbiah, MD https://lnkd.in/gCCVWzGa #oncodaily #oncology #cancer #AACR24 #OncologyClinicalTrials #NextGenOncology #InclusiveResearch #CancerConquerors #DemocratizeOncology

In a recent UNC Lineberger Comprehensive Cancer Center Q&A, Kirsten Bryant, Ph.D., discusses what motivates her in the lab, how mentorship and advocacy have fueled her passion for pancreatic cancer research, and more. https://lnkd.in/gWFpsfWd #PancreaticCancer #Oncology #CancerResearch

Project Spotlight: Synergy Oncology (Nova Scotia) Synergy Spheres, a groundbreaking development in Selective Internal Radiation Therapy (SIRT), represent a significant leap forward in cancer treatment. These third-generation microspheres promise to redefine personalized cancer care, especially for extra-hepatic cancers.   Featuring enhanced physical integrity and precise imaging capabilities, Synergy Spheres offer unparalleled delivery accuracy and real-time monitoring. Their adaptability to carry various therapeutic radionuclides allows for tailored treatment plans, optimizing outcomes across different cancer types. Backed by CMIEDF funding, Synergy Oncology aims to refine and validate the product through rigorous laboratory testing, paving the way for clinical trials in 2025. This advancement holds the potential to revolutionize cancer treatment, offering hope to patients worldwide.

As of January 31, 2024, there are 12,588 trials that have enrolled or plan to enroll breast cancer patients. See our full analysis of this important indication: https://hubs.ly/Q02mGGfj0 #oncology #clinicaltrials #drugdevelopment

How AACI (Association of American Cancer Institutes) cancer centers and other institutions can shift from a transactional model to form mutually beneficial partnerships and collaborations https://lnkd.in/gaQsVTp5 #oncodaily #oncology #cancerresearch #globalhealth #cancercenter #collaboration #partnerships #globaloncology